These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27964994)

  • 1. Magnetic resonance spectroscopy and brain volumetry in mild cognitive impairment. A prospective study.
    Fayed N; Modrego PJ; García-Martí G; Sanz-Requena R; Marti-Bonmatí L
    Magn Reson Imaging; 2017 May; 38():27-32. PubMed ID: 27964994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
    Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
    Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
    Modrego PJ; Fayed N; Pina MA
    Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
    Targosz-Gajniak MG; Siuda JS; Wicher MM; Banasik TJ; Bujak MA; Augusciak-Duma AM; Opala G
    J Neurol Sci; 2013 Dec; 335(1-2):58-63. PubMed ID: 24035276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study.
    Modrego PJ; Fayed N; Sarasa M
    BMJ Open; 2011 Feb; 1(1):e000007. PubMed ID: 22021723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Arlt S; Buchert R; Spies L; Eichenlaub M; Lehmbeck JT; Jahn H
    Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):335-44. PubMed ID: 22940716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the conversion of mild cognitive impairment to Alzheimer's disease based on the volumetric measurements of the selected brain structures in magnetic resonance imaging.
    Nesteruk M; Nesteruk T; Styczyńska M; Barczak A; Mandecka M; Walecki J; Barcikowska-Kotowicz M
    Neurol Neurochir Pol; 2015; 49(6):349-53. PubMed ID: 26652867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia.
    Fayed N; Dávila J; Oliveros A; Castillo J; Medrano JJ
    Acad Radiol; 2008 Sep; 15(9):1089-98. PubMed ID: 18692749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
    Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
    Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric MRI for the improved diagnostic accuracy of Alzheimer's disease and mild cognitive impairment: Research protocol of a case-control study design.
    Piersson AD; Ibrahim B; Suppiah S; Mohamad M; Hassan HA; Omar NF; Ibrahim MI; Yusoff AN; Ibrahim N; Saripan MI; Razali RM
    PLoS One; 2021; 16(9):e0252883. PubMed ID: 34547018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
    López ME; Turrero A; Cuesta P; López-Sanz D; Bruña R; Marcos A; Gil P; Yus M; Barabash A; Cabranes JA; Maestú F; Fernández A
    J Alzheimers Dis; 2016 Mar; 52(1):133-43. PubMed ID: 27060953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.
    Londono AC; Castellanos FX; Arbelaez A; Ruiz A; Aguirre-Acevedo DC; Richardson AM; Easteal S; Lidbury BA; Arcos-Burgos M; Lopera F
    Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampus and Basal Forebrain Volumetry for Dementia and Mild Cognitive Impairment Diagnosis: Could It Be Useful in Primary Care?
    Teipel SJ; Keller F; Thyrian JR; Strohmaier U; Altiner A; Hoffmann W; Kilimann I
    J Alzheimers Dis; 2017; 55(4):1379-1394. PubMed ID: 27834778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).
    Walecki J; Barcikowska M; Ćwikła JB; Gabryelewicz T
    Med Sci Monit; 2011 Dec; 17(12):MT105-11. PubMed ID: 22129910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].
    Martínez-Bisbal MC; Arana E; Martí-Bonmatí L; Martínez-Granados B; Celda B
    Radiologia; 2006; 48(5):301-7. PubMed ID: 17168239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI and MRS predictors of mild cognitive impairment in a population-based sample.
    Kantarci K; Weigand SD; Przybelski SA; Preboske GM; Pankratz VS; Vemuri P; Senjem ML; Murphy MC; Gunter JL; Machulda MM; Ivnik RJ; Roberts RO; Boeve BF; Rocca WA; Knopman DS; Petersen RC; Jack CR
    Neurology; 2013 Jul; 81(2):126-33. PubMed ID: 23761624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
    Fayed N; Dávila J; Oliveros A; Medrano J; Castillo J
    Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
    Waragai M; Moriya M; Nojo T
    J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
    Brueggen K; Dyrba M; Barkhof F; Hausner L; Filippi M; Nestor PJ; Hauenstein K; Klöppel S; Grothe MJ; Kasper E; Teipel SJ
    J Alzheimers Dis; 2015; 48(1):197-204. PubMed ID: 26401940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment.
    Ardekani BA; Bermudez E; Mubeen AM; Bachman AH;
    J Alzheimers Dis; 2017; 55(1):269-281. PubMed ID: 27662309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.